Phase 2 clinical trial of Russia’s second new crown vaccine is expected to end in September
Russia’s second new crown vaccine, developed by the State Science Center of vector virology and biotechnology, is undergoing phase 2 clinical trials, with 43 volunteers vaccinated in the phase 2 trial, the Russian Federal Bureau of consumer protection and public welfare Supervision said on the 21st. At present, the volunteers feel good on the whole without obvious side effects. Phase 2 clinical trials are expected to end in September.
